I’d buy these 3 FTSE 100 dividend stocks to generate a rising passive income and retire early

If you’re looking to build a rising passive income from FTSE 100 dividend stocks, I think these three could be worth a place in your investment portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors can still find plenty of FTSE 100 dividend stocks paying generous levels of income, despite the Covid-19 crash. You can reinvest those payouts while still working, then use them to top up your pension when you retire.

Dividend stocks should generate a rising income over time, as most companies endeavour to increase their payments year after year. Better still, it’s a passive income, which means you don’t have to do anything to earn it. FTSE 100 dividend stocks like these three could even help you retire early.

Pharmaceutical giant GlaxoSmithKline (LSE: GSK) has been a FTSE 100 dividend hero for years, and remains a top income stock today. While investors have been disappointed by management’s decision to freeze the payout at 80p a share for the last few years, it’s always seemed a sensible move to me. It allows the company to pump more money into its drugs pipeline, to build future revenues.

I’d buy this FTSE 100 dividend stock today

Investors can hardly complain, given the stock currently yields 5.47%. That’s a terrific income, especially with the base interest rate at 0.01%. It’ll look even better if we get negative rates. Cover is reasonable, at 1.5 times earnings.

Better still, the Glaxo share price is relatively cheap right now, trading at 11.62 times earnings. It has been drifting downwards lately, and trades around 12% lower than six months ago. This looks like one of the most compelling FTSE 100 dividend stocks today.

Most FTSE 100 dividend income investors will already have Glaxo on their radar, but some may have overlooked another top stock, fund manager Schroders (LSE: SDR). It currently yields 4.05%, and cover is better here at 1.7 times earnings.

Asset managers are often seen as a geared play on the stock market and, inevitably, the Schroders share price fell in the March crash. It has recovered strongly though and, in contrast to Glaxo, is up 12% in the last six months.

With global central bankers effectively backstopping share prices, the risk is greatly reduced. You can still buy it at a discounted valuation of 13.95 times earnings. Schroders has a great long-term pedigree, and looks like another tempting FTSE 100 dividend stock for those seeking rising passive income.

This rising passive income could be yours

Plumbing and heating products distributor Ferguson (LSE: FERG) is a play on the US economy, as it generates more than 90% of its revenues from the States. However, investors should not overlook its income capabilities as well.

Ferguson suspended its dividend earlier this year but has now restored its payout after trading picked up. Revenues fell by just 0.9% to $21.8bn in the year to 31 July, with pre-tax profit down 4.8% to $1.3bn. These figures look assuring given today’s uncertainties. 

This FTSE 100 dividend stock may only yield 2.6%, but the payout is handsomely covered 2.7 times, giving scope for progression. The Ferguson share price is more expensive, at 20.2 times earnings. Maybe start with Glaxo and Schroders, and keep Ferguson on your watch list.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Will the S&P 500 crash in 2026?

The S&P 500 delivered impressive gains in 2025, but valuations are now running high. Are US stocks stretched to breaking…

Read more »

Teenage boy is walking back from the shop with his grandparent. He is carrying the shopping bag and they are linking arms.
Investing Articles

How much do you need in a SIPP to generate a brilliant second income of £2,000 a month?

Harvey Jones crunches the numbers to show how investors can generate a high and rising passive income from a portfolio…

Read more »

Investing Articles

Will Lloyds shares rise 76% again in 2026?

What needs to go right for Lloyds shares to post another 76% rise? Our Foolish author dives into what might…

Read more »

Investing Articles

How much passive income will I get from investing £10,000 in an ISA for 10 years?

Harvey Jones shows how he plans to boost the amount of passive income he gets when he retires, from FTSE…

Read more »

Investing Articles

Down 34% in 2025 — but could this be one of the UK’s top growth stocks for 2026?

With clarity over research funding on the horizon, could Judges Scientific be one of the UK’s best growth stocks to…

Read more »

piggy bank, searching with binoculars
Investing Articles

Can the rampant Barclays share price beat Lloyds in 2026?

Harvey Jones says the Barclays share price was neck and neck with Lloyds over the last year, and checks out…

Read more »

Investing Articles

Here’s how Rolls-Royce shares could hit £25 in 2026

If Rolls-Royce shares continue their recent performance, then £25 might be on the cards for 2026. Let's take a look…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

Prediction: in 2026 the red-hot Rolls-Royce share price could turn £10,000 into…

Harvey Jones can't believe how rapidlly the Rolls-Royce share price has climbed. Now he looks at the FTSE 100 growth…

Read more »